John Castellani, CEO of PhRMA, Appointed to Pharmacist Partners'® Advisory Board

The announcement was made today by Pharmacist Partners, The Clinical Knowledge Organization™ (CKO). As a CKO, Pharmacist Partners utilizes pharmacists to provide education and advocacy to healthcare practitioners on behalf of its pharmaceutical clients.

NEW YORK, May 14, 2013 /PRNewswire-iReach/ -- Mr. Castellani, one of the most respected visionaries in Corporate America, has been appointed to Pharmacist Partners' Advisory Board. Currently, Mr. Castellani leads PhRMA, an organization representing America's foremost pharmaceutical research and biotechnology companies. PhRMA's membership includes more than half a million healthcare professionals from the most innovative research-based companies in the world. In his leadership role at PhRMA, as well as in the industry, Mr. Castellani spearheads initiatives designed to promote innovative and patient-centered solutions to health care challenges.


"I am proud to join the Advisory Board of Pharmacist Partners to help advance our shared objectives of improving medication literacy and adherence to medicines – all of which are focused on helping patients enjoy healthier lives. Improving patient health requires constructive and informed engagement among all stakeholders in the health care delivery chain, including pharmacists, prescribers and biopharmaceutical research companies," said PhRMA President and CEO John J. Castellani. "A growing body of evidence demonstrates that improving adherence to prescribed medicines and therapies leads to better health outcomes and helps to reduce costs in other areas of health care, such as hospitalization and surgery."

"We are delighted to have John Castellani accept this position on our Advisory Board," said David Perry, CEO of Pharmacist Partners.  "As we bring our unique business model and capabilities to a broad range of client engagements, John's extensive expertise will be invaluable to our leadership team. As a company focused on elevating medical literacy among patients to improve adherence rates, we feel particularly fortunate to have someone with such a vast knowledge of the biopharmaceutical industry join our board."

As the only Clinical Knowledge Organization in existence, Pharmacist Partners is dedicated to improving patient health and quality of life by leveraging the knowledge and education of its clinical staff. On behalf of its clients, Pharmacist Partners provides a network of pharmacists who act as consultants and adherence advocates to interact with healthcare practitioners in the field.  As experienced pharmacists themselves, these consultants possess a clinical acumen that brings peer credibility to these interactions. They are knowledgeable advocates for viable solutions to medication literacy and adherence issues, both of which are key directives of the pharmaceutical industry and the pharmacists.

With such current industry challenges as shrinking sales forces and a heightened focus on outcomes, Pharmacist Partners' consultants are focused on addressing these issues, which impact the providers, drug manufacturers and, most importantly, the patients. These pharmacist consultants may also prove to be of value to pharmaceutical companies dealing with seasonal needs or product launches, by their ability to provide feedback to those companies.

Presentation June 4th in Philadephia: 

John Castellani, Jack Kelly R.Ph. (Chief Business Officer, Pharmacist Partners), and Dr. Salvatore Giorgianni (Chair, Men's Health Caucus, and Advisor to Pharmacist Partners) will be co-presenting at the upcoming 11th Annual eyeforpharma Philadelphia,  on June 4, 2013.

Medication adherence and Patient-centricity solutions will be key topics discussed at the event.  This unique panel will be moderated by Kevin Dolgin, President of Observia, a French company providing patient compliance programs.  Kevin is also Associate Professor of Marketing at the Sorbonne Graduate Business School.

Why was Pharmacist Partners created?

In the arena of contract sales organizations, the cookie cutter, mass-market pharmaceutical blockbuster era is over. Along with its demise went the old sales model of deploying massive numbers of non-clinical sales personnel to detail physicians and other prescribers as a way of achieving a greater share–of-voice in the market.

Today, most new products are in such niche areas as vaccines, oncology and biologicals. These new products cater to specific markets, and as a result, require clinicians to have a greater level of knowledge of their benefits and risks. Pharmacist Partners was established to address the need for a highly skilled "Clinical Knowledge Organization" to provide the level of clinical experience and knowledge that only our staff of pharmacist partners can offer.

For more information, contact David Perry, CEO, Pharmacist Partners at 855-742-7611.


Media Contact: David Perry, Pharmacist Partners, 917-238-2456,

News distributed by PR Newswire iReach:


SOURCE Pharmacist Partners



Biotechnology, Health Care & Hospitals, Health Insurance, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements

Need Help